Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Aruba Science Wire.
Press releases published on August 15, 2025
Viomi Technology Co., Ltd Announces Preliminary First Half 2025 Financial
GlobeNewswire
·
August 15, 2025
GUANGZHOU, China, Aug. 15, 2025 (GLOBE NEWSWIRE) -- Viomi Technology Co., Ltd (“Viomi” or the “Company”) (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced its preliminary, unaudited revenue for the first half …
To “Eat” or to “Escape”? NTHU Uncovers Olfactory Code of Fruit Fly Brain
GlobeNewswire
·
August 15, 2025
HSINCHU, Taiwan, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The Director of the Brain Research Center at National Tsing Hua University (NTHU) in Taiwan, Ann-Shyn Chiang (江安世), Professor of the Institute for Systems Neuroscience, Chung-Chuan Lo (羅中泉), and …
Santhera verlängert Wandelanleihe von Highbridge bis zum 30. September 2025
GlobeNewswire
·
August 15, 2025
Ad hoc-Mitteilung gemäss Art. 53 KR Pratteln, Schweiz, 15. August 2025 – Santhera Pharmaceuticals (SIX: SANN) gibt bekannt, dass das Unternehmen und Highbridge Capital Management, LLC (Highbridge) einvernehmlich beschlossen haben, die Laufzeit der …
Santhera extends Highbridge convertible bond to 30th September 2025
GlobeNewswire
·
August 15, 2025
Ad hoc announcement pursuant to Art. 53 LRA Pratteln, Switzerland, 15 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces that by mutual agreement the Company and Highbridge Capital Management, LLC (Highbridge) have decided to extend the maturity …
Propanc Biopharma Announces Nasdaq Uplisting and Pricing of $4 Million Public Offering
GlobeNewswire
·
August 15, 2025
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today …
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with First Phase 1B/2 Trial Readout Expected in 2H 2025
GlobeNewswire
·
August 15, 2025
Breakthrough Protein Phosphatase 2A inhibitor LB-100 Targets Ovarian Clear Cell Carcinoma, Advanced Soft Tissue Sarcoma, and MSS Metastatic Colon Cancer 24/7 Market News Issues Corrected Information on Previously issued Press Release with same title DENVER …